Correlation Between CSL and Zealand Pharma
Can any of the company-specific risk be diversified away by investing in both CSL and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL Limited and Zealand Pharma AS, you can compare the effects of market volatilities on CSL and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Zealand Pharma.
Diversification Opportunities for CSL and Zealand Pharma
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CSL and Zealand is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding CSL Limited and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL Limited are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of CSL i.e., CSL and Zealand Pharma go up and down completely randomly.
Pair Corralation between CSL and Zealand Pharma
Assuming the 90 days horizon CSL Limited is expected to generate 0.8 times more return on investment than Zealand Pharma. However, CSL Limited is 1.25 times less risky than Zealand Pharma. It trades about -0.08 of its potential returns per unit of risk. Zealand Pharma AS is currently generating about -0.1 per unit of risk. If you would invest 20,238 in CSL Limited on September 3, 2024 and sell it today you would lose (2,863) from holding CSL Limited or give up 14.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 96.92% |
Values | Daily Returns |
CSL Limited vs. Zealand Pharma AS
Performance |
Timeline |
CSL Limited |
Zealand Pharma AS |
CSL and Zealand Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CSL and Zealand Pharma
The main advantage of trading using opposite CSL and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.CSL vs. Pmv Pharmaceuticals | CSL vs. Novo Nordisk AS | CSL vs. Kalvista Pharmaceuticals | CSL vs. ProKidney Corp |
Zealand Pharma vs. NewAmsterdam Pharma | Zealand Pharma vs. Portage Biotech | Zealand Pharma vs. DBV Technologies | Zealand Pharma vs. NewAmsterdam Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |